by BajpayeeLab | Oct 14, 2026 | Uncategorized
Congratulations to Dr. Tim Boyer and co-authors for publishing in Arthritis Research & Therapy an insightful and very much needed review on IL-1 inhibition strategies as a therapeutic strategy for OA! IL-1 inhibition has been a widely researched avenue of tackling... 
by BajpayeeLab | Oct 12, 2026 | Uncategorized
With US National Nanotechnology Day on October 9th, Nanoscale highlighted a series of articles published by US authors in their journals, including our sustained release of neosaxitoxin work led by Dr. Hengli Zhang! Congratulations to Dr. Hengli Zhang and co-authors... 
by BajpayeeLab | Sep 30, 2026 | Uncategorized
Our lab has been awarded a $3.1M NIH R01 Grant – Cartilage targeting exosomes for OA gene therapy and pain treatment! This project will continue our work on developing charge-reversed exosomes for non-viral gene therapy in OA. Prof. Rachel Miller from Rush... 
by BajpayeeLab | Sep 8, 2026 | Uncategorized
Congratulations to Dr. Helna Baby on successfully defending her doctoral thesis! Helna’s work ranged from engineering of PLGA microparticles for targeted delivery of RhoA to nucleus pulposus for IVDD therapy to charge-reversed exosomes for mRNA gene delivery to... 
by BajpayeeLab | Jul 19, 2026 | Uncategorized
Congratulations to Dr. Bill Hakim for successfully defending his doctoral thesis! Bill’s work focused on the development of IGF-1 fusion proteins for cartilage regeneration for OA therapy. We will miss his steadfast presence in lab and look forward to seeing all... 
by BajpayeeLab | May 19, 2026 | Uncategorized
Congratulations to Dr. Hengli Zhang for successfully defending his doctoral thesis! Hengli’s work focused on the delivery of anesthetics for OA through a variety of different methods including PLGA microparticles, fusion proteins, and exosomes. We look forward...